JP2006523711A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006523711A5 JP2006523711A5 JP2006510118A JP2006510118A JP2006523711A5 JP 2006523711 A5 JP2006523711 A5 JP 2006523711A5 JP 2006510118 A JP2006510118 A JP 2006510118A JP 2006510118 A JP2006510118 A JP 2006510118A JP 2006523711 A5 JP2006523711 A5 JP 2006523711A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- seq
- composition according
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46334203P | 2003-04-17 | 2003-04-17 | |
| PCT/US2004/011767 WO2004093894A2 (en) | 2003-04-17 | 2004-04-16 | Use of b7-h3 as an immunoregulatory agent |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007095108A Division JP2007191489A (ja) | 2003-04-17 | 2007-03-30 | 免疫調節因子としてのｂ７−ｈ３の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006523711A JP2006523711A (ja) | 2006-10-19 |
| JP2006523711A5 true JP2006523711A5 (enExample) | 2007-05-24 |
Family
ID=33310770
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006510118A Withdrawn JP2006523711A (ja) | 2003-04-17 | 2004-04-16 | 免疫調節因子としてのｂ７−ｈ３の使用 |
| JP2007095108A Withdrawn JP2007191489A (ja) | 2003-04-17 | 2007-03-30 | 免疫調節因子としてのｂ７−ｈ３の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007095108A Withdrawn JP2007191489A (ja) | 2003-04-17 | 2007-03-30 | 免疫調節因子としてのｂ７−ｈ３の使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20050002935A1 (enExample) |
| EP (1) | EP1620119A2 (enExample) |
| JP (2) | JP2006523711A (enExample) |
| KR (1) | KR20060017496A (enExample) |
| CN (1) | CN1809370A (enExample) |
| AU (1) | AU2004231748A1 (enExample) |
| BR (1) | BRPI0409476A (enExample) |
| CA (1) | CA2521847A1 (enExample) |
| CO (1) | CO5700783A2 (enExample) |
| MX (1) | MXPA05011050A (enExample) |
| NO (1) | NO20054790L (enExample) |
| RU (1) | RU2005135739A (enExample) |
| WO (1) | WO2004093894A2 (enExample) |
| ZA (1) | ZA200508367B (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030031675A1 (en) | 2000-06-06 | 2003-02-13 | Mikesell Glen E. | B7-related nucleic acids and polypeptides useful for immunomodulation |
| MXPA02012106A (es) | 2000-06-06 | 2003-06-06 | Bristol Myers Squibb Co | Polipeptidos y acidos nucleicos relacionados con b7 empleados para inmunomodulacion. |
| AU2003292696A1 (en) | 2002-12-26 | 2004-08-10 | Takeda Pharmaceutical Company Limited | Metastin derivative and use thereof |
| CN101845091A (zh) | 2004-06-25 | 2010-09-29 | 武田药品工业株式会社 | 转移素衍生物及其用途 |
| TWI386417B (zh) | 2005-12-22 | 2013-02-21 | Takeda Pharmaceutical | 轉移抑素衍生物及其用途 |
| US8404643B2 (en) | 2005-12-22 | 2013-03-26 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| JO3048B1 (ar) | 2006-10-25 | 2016-09-05 | Takeda Pharmaceuticals Co | مشتقات متاستين واستخدامها |
| JP5601836B2 (ja) * | 2006-11-08 | 2014-10-08 | マクロジェニックス ウエスト， インコーポレイテッド | Ｔｅｓ７およびｔｅｓ７に結合する抗体 |
| PH12012501751A1 (en) | 2010-03-04 | 2012-11-12 | Macrogenics Inc | Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof |
| SG10201604336VA (en) | 2010-03-04 | 2016-07-28 | Macrogenics Inc | Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof |
| PH12013502201A1 (en) * | 2011-04-25 | 2014-01-13 | Daiichi Sankyo Co Ltd | Anti-b7-h3 antibody |
| US9487587B2 (en) | 2013-03-05 | 2016-11-08 | Macrogenics, Inc. | Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof |
| AU2015217278B2 (en) | 2014-02-14 | 2020-03-19 | Macrogenics, Inc. | Improved methods for the treatment of vascularizing cancers |
| RU2731202C2 (ru) | 2015-10-08 | 2020-08-31 | Макродженикс, Инк. | Комбинированная терапия для лечения рака |
| US10961311B2 (en) | 2016-04-15 | 2021-03-30 | Macrogenics, Inc. | B7-H3 binding molecules, antibody drug conjugates thereof and methods of use thereof |
| US10899837B2 (en) * | 2017-03-31 | 2021-01-26 | Jiangsu Hengrui Medicine Co., Ltd. | B7-H3 antibody, antigen-binding fragment thereof and medical use thereof |
| CN109097366A (zh) * | 2017-06-21 | 2018-12-28 | 黄海东 | 突变的人2Ig-B7-H3蛋白编码基因、重组载体、其药物组合物及其应用 |
| WO2020094120A1 (zh) | 2018-11-09 | 2020-05-14 | 上海复旦张江生物医药股份有限公司 | 一种抗b7-h3抗体及其制备方法、其偶联物和应用 |
| CN113260703A (zh) * | 2018-12-24 | 2021-08-13 | 黄海东 | 突变的人2Ig-B7-H3蛋白编码基因、重组载体、包含其的宿主细胞、药物组合物及其应用 |
| CN118878681A (zh) * | 2019-07-18 | 2024-11-01 | 泰州复旦张江药业有限公司 | 一种抗b7-h3抗体及其制备方法、其偶联物和应用 |
| CN111454357B (zh) * | 2019-08-14 | 2022-03-15 | 康诺亚生物医药科技（成都）有限公司 | 一种含有抗体的肿瘤治疗剂的开发和应用 |
| CN111088227A (zh) * | 2019-12-31 | 2020-05-01 | 广州航华生物医药科技有限公司 | 一种细胞分离培养液和t细胞分离培养的方法 |
| CN119504997A (zh) | 2021-02-09 | 2025-02-25 | 苏州宜联生物医药有限公司 | 生物活性物偶联物及其制备方法和用途 |
| CN113144181B (zh) * | 2021-04-20 | 2022-07-19 | 徐州医科大学 | 一种靶向b7h3的dna疫苗、制备方法及应用 |
| WO2023155808A1 (zh) | 2022-02-16 | 2023-08-24 | 苏州宜联生物医药有限公司 | 抗体-艾日布林或其衍生物的偶联物、其中间体、制备方法、药物组合物和用途 |
| US20250325688A1 (en) | 2022-05-18 | 2025-10-23 | Medilink Therapeutics (Suzhou) Co., Ltd. | Antibody-drug conjugate containing protein degradation agent bioactive compound, method for preparing same, and use thereof |
| CN120898001A (zh) * | 2023-01-10 | 2025-11-04 | 上海仁又生基因技术有限公司 | 重组人2Ig-B7-H3蛋白编码基因、重组载体、宿主细胞、药物组合物及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02012106A (es) * | 2000-06-06 | 2003-06-06 | Bristol Myers Squibb Co | Polipeptidos y acidos nucleicos relacionados con b7 empleados para inmunomodulacion. |
| WO2002010187A1 (en) * | 2000-07-27 | 2002-02-07 | Mayo Foundation For Medical Education And Research | B7-h3 and b7-h4, novel immunoregulatory molecules |
| US20040236088A1 (en) * | 2001-08-02 | 2004-11-25 | Heuer Josef Georg | Novel polypeptide analogs and fusions and their methods of use |
-
2004
- 2004-04-15 US US10/824,481 patent/US20050002935A1/en not_active Abandoned
- 2004-04-16 EP EP04750222A patent/EP1620119A2/en not_active Withdrawn
- 2004-04-16 JP JP2006510118A patent/JP2006523711A/ja not_active Withdrawn
- 2004-04-16 MX MXPA05011050A patent/MXPA05011050A/es not_active Application Discontinuation
- 2004-04-16 RU RU2005135739/13A patent/RU2005135739A/ru not_active Application Discontinuation
- 2004-04-16 KR KR1020057019786A patent/KR20060017496A/ko not_active Withdrawn
- 2004-04-16 AU AU2004231748A patent/AU2004231748A1/en not_active Abandoned
- 2004-04-16 CN CNA2004800170492A patent/CN1809370A/zh not_active Withdrawn
- 2004-04-16 BR BRPI0409476-0A patent/BRPI0409476A/pt not_active IP Right Cessation
- 2004-04-16 CA CA002521847A patent/CA2521847A1/en not_active Abandoned
- 2004-04-16 WO PCT/US2004/011767 patent/WO2004093894A2/en not_active Ceased
-
2005
- 2005-10-14 ZA ZA200508367A patent/ZA200508367B/en unknown
- 2005-10-18 NO NO20054790A patent/NO20054790L/no not_active Application Discontinuation
- 2005-11-17 CO CO05116756A patent/CO5700783A2/es not_active Application Discontinuation
-
2007
- 2007-03-30 JP JP2007095108A patent/JP2007191489A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006523711A5 (enExample) | ||
| Kim et al. | Regulatory T cells in tumor microenvironment and approach for anticancer immunotherapy | |
| JP2022137020A (ja) | 抗ｃｄ７０キメラ抗原受容体 | |
| AU2024287134A1 (en) | Multi-chain chimeric polypeptides and uses there | |
| AU2025237926A1 (en) | Nanoparticle compositions for sustained therapy | |
| ES2925307T3 (es) | Receptores de linfocitos T que reconocen MAGE-A3 restringida al MHC de clase II | |
| JP2004248677A5 (enExample) | ||
| Wiesel et al. | Virus‐specific CD8 T cells: activation, differentiation and memory formation | |
| JP2016502512A5 (enExample) | ||
| RU2005135739A (ru) | Способ регулирования активации лимфоцита (варианты) | |
| JP2010529860A5 (enExample) | ||
| JP2015508757A5 (enExample) | ||
| JP2018029594A5 (enExample) | ||
| BR112019009477A2 (pt) | moléculas de classe ii de pmhc recombinantes | |
| JP2010273685A5 (enExample) | ||
| EP3714042A1 (en) | Use and production of engineered immune cells | |
| JP2013505734A5 (enExample) | ||
| JP2013513377A5 (enExample) | ||
| JP2019513394A5 (enExample) | ||
| JP2019530441A5 (enExample) | ||
| CN116529360A (zh) | 用于刺激γδT细胞的方法和组合物 | |
| JP2011523849A5 (enExample) | ||
| JP2011520989A5 (enExample) | ||
| PE20100141A1 (es) | Proteina de union al receptor de interleuquina 21 | |
| JP2015519355A5 (enExample) |